nodes	percent_of_prediction	percent_of_DWPC	metapath
Arsenic trioxide—CCND1—pharynx cancer	0.826	1	CbGaD
Arsenic trioxide—CCND1—larynx—pharynx cancer	0.00833	0.104	CbGeAlD
Arsenic trioxide—CCND1—mouth—pharynx cancer	0.00258	0.0323	CbGeAlD
Arsenic trioxide—CCND1—neck—pharynx cancer	0.00221	0.0276	CbGeAlD
Arsenic trioxide—MAPK1—mouth—pharynx cancer	0.00218	0.0272	CbGeAlD
Arsenic trioxide—TXNRD1—mouth—pharynx cancer	0.00203	0.0253	CbGeAlD
Arsenic trioxide—MAPK3—mouth—pharynx cancer	0.00193	0.0241	CbGeAlD
Arsenic trioxide—AKT1—mouth—pharynx cancer	0.00182	0.0227	CbGeAlD
Arsenic trioxide—CCND1—parotid gland—pharynx cancer	0.0018	0.0225	CbGeAlD
Arsenic trioxide—CCND1—saliva-secreting gland—pharynx cancer	0.00172	0.0216	CbGeAlD
Arsenic trioxide—MAPK3—neck—pharynx cancer	0.00165	0.0206	CbGeAlD
Arsenic trioxide—JUN—mouth—pharynx cancer	0.00158	0.0198	CbGeAlD
Arsenic trioxide—AKT1—neck—pharynx cancer	0.00155	0.0194	CbGeAlD
Arsenic trioxide—CCND1—epithelium—pharynx cancer	0.0015	0.0188	CbGeAlD
Arsenic trioxide—MAPK1—brainstem—pharynx cancer	0.00142	0.0178	CbGeAlD
Arsenic trioxide—TXNRD1—parotid gland—pharynx cancer	0.00141	0.0177	CbGeAlD
Arsenic trioxide—JUN—neck—pharynx cancer	0.00135	0.0169	CbGeAlD
Arsenic trioxide—TXNRD1—saliva-secreting gland—pharynx cancer	0.00135	0.0169	CbGeAlD
Arsenic trioxide—MAPK3—parotid gland—pharynx cancer	0.00134	0.0168	CbGeAlD
Arsenic trioxide—CCND1—trachea—pharynx cancer	0.00133	0.0166	CbGeAlD
Arsenic trioxide—MAPK3—saliva-secreting gland—pharynx cancer	0.00129	0.0161	CbGeAlD
Arsenic trioxide—MAPK1—epithelium—pharynx cancer	0.00127	0.0158	CbGeAlD
Arsenic trioxide—AKT1—parotid gland—pharynx cancer	0.00127	0.0158	CbGeAlD
Arsenic trioxide—AKT1—saliva-secreting gland—pharynx cancer	0.00121	0.0152	CbGeAlD
Arsenic trioxide—AKT1—brainstem—pharynx cancer	0.00119	0.0148	CbGeAlD
Arsenic trioxide—TXNRD1—epithelium—pharynx cancer	0.00118	0.0147	CbGeAlD
Arsenic trioxide—CCND1—lymphoid tissue—pharynx cancer	0.00116	0.0145	CbGeAlD
Arsenic trioxide—MAPK3—epithelium—pharynx cancer	0.00112	0.014	CbGeAlD
Arsenic trioxide—JUN—parotid gland—pharynx cancer	0.0011	0.0138	CbGeAlD
Arsenic trioxide—AKT1—epithelium—pharynx cancer	0.00106	0.0132	CbGeAlD
Arsenic trioxide—JUN—saliva-secreting gland—pharynx cancer	0.00106	0.0132	CbGeAlD
Arsenic trioxide—CCND1—spinal cord—pharynx cancer	0.00105	0.0131	CbGeAlD
Arsenic trioxide—TXNRD1—trachea—pharynx cancer	0.00104	0.013	CbGeAlD
Arsenic trioxide—JUN—brainstem—pharynx cancer	0.00103	0.0129	CbGeAlD
Arsenic trioxide—MAPK3—trachea—pharynx cancer	0.000992	0.0124	CbGeAlD
Arsenic trioxide—MAPK1—lymphoid tissue—pharynx cancer	0.000976	0.0122	CbGeAlD
Arsenic trioxide—AKT1—trachea—pharynx cancer	0.000935	0.0117	CbGeAlD
Arsenic trioxide—CCND1—head—pharynx cancer	0.000933	0.0117	CbGeAlD
Arsenic trioxide—JUN—epithelium—pharynx cancer	0.00092	0.0115	CbGeAlD
Arsenic trioxide—TXNRD1—lymphoid tissue—pharynx cancer	0.000908	0.0114	CbGeAlD
Arsenic trioxide—MAPK1—spinal cord—pharynx cancer	0.000885	0.0111	CbGeAlD
Arsenic trioxide—MAPK3—lymphoid tissue—pharynx cancer	0.000864	0.0108	CbGeAlD
Arsenic trioxide—TXNRD1—spinal cord—pharynx cancer	0.000823	0.0103	CbGeAlD
Arsenic trioxide—AKT1—lymphoid tissue—pharynx cancer	0.000814	0.0102	CbGeAlD
Arsenic trioxide—JUN—trachea—pharynx cancer	0.000814	0.0102	CbGeAlD
Arsenic trioxide—MAPK1—head—pharynx cancer	0.000786	0.00983	CbGeAlD
Arsenic trioxide—MAPK3—spinal cord—pharynx cancer	0.000783	0.00979	CbGeAlD
Arsenic trioxide—AKT1—spinal cord—pharynx cancer	0.000738	0.00923	CbGeAlD
Arsenic trioxide—TXNRD1—head—pharynx cancer	0.000732	0.00915	CbGeAlD
Arsenic trioxide—JUN—lymphoid tissue—pharynx cancer	0.000709	0.00886	CbGeAlD
Arsenic trioxide—IKBKB—lymphoid tissue—pharynx cancer	0.000705	0.00882	CbGeAlD
Arsenic trioxide—MAPK3—head—pharynx cancer	0.000696	0.0087	CbGeAlD
Arsenic trioxide—AKT1—head—pharynx cancer	0.000656	0.00821	CbGeAlD
Arsenic trioxide—CCND1—lymph node—pharynx cancer	0.000653	0.00817	CbGeAlD
Arsenic trioxide—JUN—spinal cord—pharynx cancer	0.000643	0.00804	CbGeAlD
Arsenic trioxide—CYP1A1—mouth—pharynx cancer	0.000596	0.00746	CbGeAlD
Arsenic trioxide—JUN—head—pharynx cancer	0.000571	0.00714	CbGeAlD
Arsenic trioxide—IKBKB—head—pharynx cancer	0.000568	0.00711	CbGeAlD
Arsenic trioxide—MAPK1—lymph node—pharynx cancer	0.000551	0.00688	CbGeAlD
Arsenic trioxide—TXNRD1—lymph node—pharynx cancer	0.000512	0.00641	CbGeAlD
Arsenic trioxide—MAPK3—lymph node—pharynx cancer	0.000487	0.00609	CbGeAlD
Arsenic trioxide—AKT1—lymph node—pharynx cancer	0.000459	0.00575	CbGeAlD
Arsenic trioxide—CYP1A1—parotid gland—pharynx cancer	0.000415	0.00519	CbGeAlD
Arsenic trioxide—JUN—lymph node—pharynx cancer	0.0004	0.005	CbGeAlD
Arsenic trioxide—IKBKB—lymph node—pharynx cancer	0.000398	0.00498	CbGeAlD
Arsenic trioxide—CYP1B1—lymphoid tissue—pharynx cancer	0.000378	0.00473	CbGeAlD
Arsenic trioxide—CYP1A1—epithelium—pharynx cancer	0.000347	0.00434	CbGeAlD
Arsenic trioxide—CYP1A1—trachea—pharynx cancer	0.000307	0.00384	CbGeAlD
Arsenic trioxide—CYP1B1—head—pharynx cancer	0.000304	0.00381	CbGeAlD
Arsenic trioxide—ABCC2—lymph node—pharynx cancer	0.000218	0.00272	CbGeAlD
Arsenic trioxide—CYP1A1—head—pharynx cancer	0.000215	0.00269	CbGeAlD
Arsenic trioxide—CYP1B1—lymph node—pharynx cancer	0.000213	0.00267	CbGeAlD
Arsenic trioxide—ABCB1—epithelium—pharynx cancer	0.00018	0.00225	CbGeAlD
Arsenic trioxide—ABCB1—trachea—pharynx cancer	0.000159	0.00199	CbGeAlD
Arsenic trioxide—CYP1A1—lymph node—pharynx cancer	0.000151	0.00188	CbGeAlD
Arsenic trioxide—ABCB1—lymphoid tissue—pharynx cancer	0.000139	0.00174	CbGeAlD
Arsenic trioxide—ABCB1—spinal cord—pharynx cancer	0.000126	0.00157	CbGeAlD
Arsenic trioxide—MAPK3—Spinal Cord Injury—CCND1—pharynx cancer	0.000122	0.00129	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways in Glioblastoma—EGFR—pharynx cancer	0.000121	0.00129	CbGpPWpGaD
Arsenic trioxide—MAPK1—Rac1/Pak1/p38/MMP-2 pathway—TP53—pharynx cancer	0.00012	0.00127	CbGpPWpGaD
Arsenic trioxide—JUN—TGF-beta Signaling Pathway—CCND1—pharynx cancer	0.000119	0.00127	CbGpPWpGaD
Arsenic trioxide—MAPK1—Spinal Cord Injury—CCND1—pharynx cancer	0.000116	0.00123	CbGpPWpGaD
Arsenic trioxide—JUN—Glucocorticoid receptor regulatory network—TP53—pharynx cancer	0.000115	0.00122	CbGpPWpGaD
Arsenic trioxide—IKBKB—Rac1/Pak1/p38/MMP-2 pathway—TP53—pharynx cancer	0.000115	0.00122	CbGpPWpGaD
Arsenic trioxide—AKT1—TGF-beta Signaling Pathway—CCND1—pharynx cancer	0.000115	0.00122	CbGpPWpGaD
Arsenic trioxide—AKT1—PI-3K cascade—EGFR—pharynx cancer	0.000114	0.00121	CbGpPWpGaD
Arsenic trioxide—JUN—Apoptosis—TP53—pharynx cancer	0.000113	0.0012	CbGpPWpGaD
Arsenic trioxide—MAPK3—L1CAM interactions—EGFR—pharynx cancer	0.000112	0.0012	CbGpPWpGaD
Arsenic trioxide—JUN—ErbB1 downstream signaling—EGFR—pharynx cancer	0.000112	0.00119	CbGpPWpGaD
Arsenic trioxide—IKBKB—p75(NTR)-mediated signaling—TP53—pharynx cancer	0.000112	0.00119	CbGpPWpGaD
Arsenic trioxide—ABCB1—head—pharynx cancer	0.000112	0.0014	CbGeAlD
Arsenic trioxide—AKT1—PI3K/AKT activation—EGFR—pharynx cancer	0.000111	0.00118	CbGpPWpGaD
Arsenic trioxide—AKT1—GAB1 signalosome—EGFR—pharynx cancer	0.00011	0.00118	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways in Glioblastoma—TP53—pharynx cancer	0.00011	0.00117	CbGpPWpGaD
Arsenic trioxide—AKT1—Glucocorticoid receptor regulatory network—TP53—pharynx cancer	0.00011	0.00117	CbGpPWpGaD
Arsenic trioxide—MAPK3—Alzheimers Disease—TP53—pharynx cancer	0.00011	0.00117	CbGpPWpGaD
Arsenic trioxide—AKT1—Apoptosis—TP53—pharynx cancer	0.000108	0.00115	CbGpPWpGaD
Arsenic trioxide—AKT1—Role of LAT2/NTAL/LAB on calcium mobilization—EGFR—pharynx cancer	0.000108	0.00115	CbGpPWpGaD
Arsenic trioxide—AKT1—ErbB1 downstream signaling—EGFR—pharynx cancer	0.000108	0.00115	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Biological oxidations—ADH1B—pharynx cancer	0.000107	0.00114	CbGpPWpGaD
Arsenic trioxide—MAPK3—Glucocorticoid receptor regulatory network—TP53—pharynx cancer	0.000107	0.00114	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways in Glioblastoma—TP53—pharynx cancer	0.000107	0.00114	CbGpPWpGaD
Arsenic trioxide—JUN—Integrated Breast Cancer Pathway—CCND1—pharynx cancer	0.000107	0.00114	CbGpPWpGaD
Arsenic trioxide—MAPK1—L1CAM interactions—EGFR—pharynx cancer	0.000107	0.00114	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Aryl Hydrocarbon Receptor—EGFR—pharynx cancer	0.000107	0.00114	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—pharynx cancer	0.000107	0.00114	CbGpPWpGaD
Arsenic trioxide—JUN—Apoptosis Modulation and Signaling—TP53—pharynx cancer	0.000106	0.00113	CbGpPWpGaD
Arsenic trioxide—MAPK1—TGF-beta Signaling Pathway—CCND1—pharynx cancer	0.000106	0.00112	CbGpPWpGaD
Arsenic trioxide—MAPK1—Alzheimers Disease—TP53—pharynx cancer	0.000105	0.00112	CbGpPWpGaD
Arsenic trioxide—MAPK3—ErbB1 downstream signaling—EGFR—pharynx cancer	0.000105	0.00111	CbGpPWpGaD
Arsenic trioxide—AKT1—Integrated Breast Cancer Pathway—CCND1—pharynx cancer	0.000103	0.00109	CbGpPWpGaD
Arsenic trioxide—MAPK1—Glucocorticoid receptor regulatory network—TP53—pharynx cancer	0.000102	0.00108	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways in Glioblastoma—TP53—pharynx cancer	0.000102	0.00108	CbGpPWpGaD
Arsenic trioxide—MAPK1—ErbB1 downstream signaling—EGFR—pharynx cancer	9.96e-05	0.00106	CbGpPWpGaD
Arsenic trioxide—MAPK3—Apoptosis Modulation and Signaling—TP53—pharynx cancer	9.85e-05	0.00105	CbGpPWpGaD
Arsenic trioxide—JUN—Wnt Signaling Pathway and Pluripotency—TP53—pharynx cancer	9.65e-05	0.00103	CbGpPWpGaD
Arsenic trioxide—IKBKB—Apoptosis—TP53—pharynx cancer	9.56e-05	0.00102	CbGpPWpGaD
Arsenic trioxide—MAPK3—Spinal Cord Injury—EGFR—pharynx cancer	9.53e-05	0.00101	CbGpPWpGaD
Arsenic trioxide—MAPK1—Integrated Breast Cancer Pathway—CCND1—pharynx cancer	9.49e-05	0.00101	CbGpPWpGaD
Arsenic trioxide—JUN—Senescence and Autophagy in Cancer—TP53—pharynx cancer	9.43e-05	0.001	CbGpPWpGaD
Arsenic trioxide—AKT1—Metabolism—CNDP2—pharynx cancer	9.19e-05	0.000978	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling by NOTCH—TP53—pharynx cancer	9.15e-05	0.000974	CbGpPWpGaD
Arsenic trioxide—JUN—DNA Damage Response (only ATM dependent)—TP53—pharynx cancer	9.15e-05	0.000974	CbGpPWpGaD
Arsenic trioxide—MAPK1—Spinal Cord Injury—EGFR—pharynx cancer	9.07e-05	0.000965	CbGpPWpGaD
Arsenic trioxide—IKBKB—Apoptosis Modulation and Signaling—TP53—pharynx cancer	8.97e-05	0.000954	CbGpPWpGaD
Arsenic trioxide—JUN—Direct p53 effectors—EGFR—pharynx cancer	8.92e-05	0.000949	CbGpPWpGaD
Arsenic trioxide—JUN—Focal Adhesion—CCND1—pharynx cancer	8.91e-05	0.000948	CbGpPWpGaD
Arsenic trioxide—JUN—Integrated Pancreatic Cancer Pathway—CCND1—pharynx cancer	8.87e-05	0.000944	CbGpPWpGaD
Arsenic trioxide—AKT1—DNA Damage Response (only ATM dependent)—TP53—pharynx cancer	8.79e-05	0.000936	CbGpPWpGaD
Arsenic trioxide—AKT1—Focal Adhesion—CCND1—pharynx cancer	8.56e-05	0.000911	CbGpPWpGaD
Arsenic trioxide—JUN—Oxidative Stress Induced Senescence—TP53—pharynx cancer	8.53e-05	0.000908	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling by SCF-KIT—EGFR—pharynx cancer	8.52e-05	0.000907	CbGpPWpGaD
Arsenic trioxide—AKT1—Integrated Pancreatic Cancer Pathway—CCND1—pharynx cancer	8.52e-05	0.000907	CbGpPWpGaD
Arsenic trioxide—JUN—Integrated Breast Cancer Pathway—EGFR—pharynx cancer	8.4e-05	0.000894	CbGpPWpGaD
Arsenic trioxide—MAPK1—Senescence and Autophagy in Cancer—TP53—pharynx cancer	8.36e-05	0.00089	CbGpPWpGaD
Arsenic trioxide—AKT1—Disease—B4GALT5—pharynx cancer	8.32e-05	0.000885	CbGpPWpGaD
Arsenic trioxide—AKT1—Metabolism—ADH7—pharynx cancer	8.31e-05	0.000884	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling by SCF-KIT—EGFR—pharynx cancer	8.27e-05	0.00088	CbGpPWpGaD
Arsenic trioxide—MAPK3—Integrated Pancreatic Cancer Pathway—CCND1—pharynx cancer	8.27e-05	0.000879	CbGpPWpGaD
Arsenic trioxide—AKT1—Downstream signaling of activated FGFR—EGFR—pharynx cancer	8.16e-05	0.000868	CbGpPWpGaD
Arsenic trioxide—AKT1—Adaptive Immune System—CD79A—pharynx cancer	8.14e-05	0.000866	CbGpPWpGaD
Arsenic trioxide—MAPK1—DNA Damage Response (only ATM dependent)—TP53—pharynx cancer	8.12e-05	0.000863	CbGpPWpGaD
Arsenic trioxide—AKT1—Integrated Breast Cancer Pathway—EGFR—pharynx cancer	8.07e-05	0.000858	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—B4GALT5—pharynx cancer	8.07e-05	0.000858	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling by ERBB4—EGFR—pharynx cancer	8.03e-05	0.000854	CbGpPWpGaD
Arsenic trioxide—MAPK3—Spinal Cord Injury—TP53—pharynx cancer	8e-05	0.000852	CbGpPWpGaD
Arsenic trioxide—MAPK3—Oxidative Stress Induced Senescence—TP53—pharynx cancer	7.95e-05	0.000846	CbGpPWpGaD
Arsenic trioxide—JUN—EGF/EGFR Signaling Pathway—EGFR—pharynx cancer	7.94e-05	0.000845	CbGpPWpGaD
Arsenic trioxide—MAPK3—Downstream signaling of activated FGFR—EGFR—pharynx cancer	7.91e-05	0.000842	CbGpPWpGaD
Arsenic trioxide—MAPK3—Regulation of Actin Cytoskeleton—EGFR—pharynx cancer	7.91e-05	0.000842	CbGpPWpGaD
Arsenic trioxide—MAPK1—Focal Adhesion—CCND1—pharynx cancer	7.9e-05	0.00084	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by SCF-KIT—EGFR—pharynx cancer	7.87e-05	0.000837	CbGpPWpGaD
Arsenic trioxide—MAPK1—Integrated Pancreatic Cancer Pathway—CCND1—pharynx cancer	7.87e-05	0.000837	CbGpPWpGaD
Arsenic trioxide—JUN—TGF-beta Signaling Pathway—TP53—pharynx cancer	7.85e-05	0.000835	CbGpPWpGaD
Arsenic trioxide—ABCB1—lymph node—pharynx cancer	7.83e-05	0.000979	CbGeAlD
Arsenic trioxide—MAPK3—Signaling by ERBB4—EGFR—pharynx cancer	7.79e-05	0.000828	CbGpPWpGaD
Arsenic trioxide—JUN—MAPK Signaling Pathway—EGFR—pharynx cancer	7.71e-05	0.00082	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—B4GALT5—pharynx cancer	7.68e-05	0.000817	CbGpPWpGaD
Arsenic trioxide—AKT1—Downstream signal transduction—EGFR—pharynx cancer	7.67e-05	0.000816	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Metabolism—CNDP2—pharynx cancer	7.64e-05	0.000813	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling by FGFR—EGFR—pharynx cancer	7.63e-05	0.000812	CbGpPWpGaD
Arsenic trioxide—AKT1—EGF/EGFR Signaling Pathway—EGFR—pharynx cancer	7.63e-05	0.000812	CbGpPWpGaD
Arsenic trioxide—MAPK1—Spinal Cord Injury—TP53—pharynx cancer	7.62e-05	0.00081	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling by ERBB2—EGFR—pharynx cancer	7.59e-05	0.000808	CbGpPWpGaD
Arsenic trioxide—MAPK1—Oxidative Stress Induced Senescence—TP53—pharynx cancer	7.57e-05	0.000805	CbGpPWpGaD
Arsenic trioxide—AKT1—DAP12 signaling—EGFR—pharynx cancer	7.55e-05	0.000804	CbGpPWpGaD
Arsenic trioxide—AKT1—TGF-beta Signaling Pathway—TP53—pharynx cancer	7.54e-05	0.000803	CbGpPWpGaD
Arsenic trioxide—MAPK1—Downstream signaling of activated FGFR—EGFR—pharynx cancer	7.53e-05	0.000801	CbGpPWpGaD
Arsenic trioxide—MAPK1—Regulation of Actin Cytoskeleton—EGFR—pharynx cancer	7.53e-05	0.000801	CbGpPWpGaD
Arsenic trioxide—JUN—Direct p53 effectors—TP53—pharynx cancer	7.49e-05	0.000797	CbGpPWpGaD
Arsenic trioxide—MAPK1—Integrated Breast Cancer Pathway—EGFR—pharynx cancer	7.45e-05	0.000792	CbGpPWpGaD
Arsenic trioxide—AKT1—Downstream signaling events of B Cell Receptor (BCR)—EGFR—pharynx cancer	7.44e-05	0.000792	CbGpPWpGaD
Arsenic trioxide—MAPK3—Downstream signal transduction—EGFR—pharynx cancer	7.44e-05	0.000791	CbGpPWpGaD
Arsenic trioxide—AKT1—MAPK Signaling Pathway—EGFR—pharynx cancer	7.41e-05	0.000788	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by ERBB4—EGFR—pharynx cancer	7.41e-05	0.000788	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling by FGFR—EGFR—pharynx cancer	7.4e-05	0.000787	CbGpPWpGaD
Arsenic trioxide—JUN—Fc epsilon receptor (FCERI) signaling—EGFR—pharynx cancer	7.4e-05	0.000787	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling by ERBB2—EGFR—pharynx cancer	7.36e-05	0.000783	CbGpPWpGaD
Arsenic trioxide—MAPK3—DAP12 signaling—EGFR—pharynx cancer	7.33e-05	0.000779	CbGpPWpGaD
Arsenic trioxide—AKT1—Metabolism—ADH1B—pharynx cancer	7.29e-05	0.000775	CbGpPWpGaD
Arsenic trioxide—MAPK3—MAPK Signaling Pathway—EGFR—pharynx cancer	7.19e-05	0.000765	CbGpPWpGaD
Arsenic trioxide—IKBKB—Adaptive Immune System—CD79A—pharynx cancer	7.19e-05	0.000765	CbGpPWpGaD
Arsenic trioxide—AKT1—Fc epsilon receptor (FCERI) signaling—EGFR—pharynx cancer	7.11e-05	0.000756	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling by FGFR in disease—EGFR—pharynx cancer	7.11e-05	0.000756	CbGpPWpGaD
Arsenic trioxide—AKT1—DAP12 interactions—EGFR—pharynx cancer	7.11e-05	0.000756	CbGpPWpGaD
Arsenic trioxide—MAPK1—Downstream signal transduction—EGFR—pharynx cancer	7.07e-05	0.000753	CbGpPWpGaD
Arsenic trioxide—JUN—Integrated Breast Cancer Pathway—TP53—pharynx cancer	7.05e-05	0.00075	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling by EGFR—EGFR—pharynx cancer	7.04e-05	0.000749	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by FGFR—EGFR—pharynx cancer	7.04e-05	0.000749	CbGpPWpGaD
Arsenic trioxide—MAPK1—EGF/EGFR Signaling Pathway—EGFR—pharynx cancer	7.04e-05	0.000749	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by ERBB2—EGFR—pharynx cancer	7.01e-05	0.000745	CbGpPWpGaD
Arsenic trioxide—JUN—Focal Adhesion—EGFR—pharynx cancer	6.99e-05	0.000744	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling by EGFR in Cancer—EGFR—pharynx cancer	6.98e-05	0.000743	CbGpPWpGaD
Arsenic trioxide—MAPK1—DAP12 signaling—EGFR—pharynx cancer	6.97e-05	0.000742	CbGpPWpGaD
Arsenic trioxide—AKT1—Metabolism—B4GALT5—pharynx cancer	6.97e-05	0.000741	CbGpPWpGaD
Arsenic trioxide—MAPK1—TGF-beta Signaling Pathway—TP53—pharynx cancer	6.96e-05	0.000741	CbGpPWpGaD
Arsenic trioxide—JUN—Integrated Pancreatic Cancer Pathway—EGFR—pharynx cancer	6.96e-05	0.00074	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling by PDGF—EGFR—pharynx cancer	6.95e-05	0.000739	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Metabolism—ADH7—pharynx cancer	6.91e-05	0.000735	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling by FGFR in disease—EGFR—pharynx cancer	6.89e-05	0.000733	CbGpPWpGaD
Arsenic trioxide—MAPK3—Fc epsilon receptor (FCERI) signaling—EGFR—pharynx cancer	6.89e-05	0.000733	CbGpPWpGaD
Arsenic trioxide—MAPK3—DAP12 interactions—EGFR—pharynx cancer	6.89e-05	0.000733	CbGpPWpGaD
Arsenic trioxide—MAPK1—MAPK Signaling Pathway—EGFR—pharynx cancer	6.84e-05	0.000727	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling by EGFR—EGFR—pharynx cancer	6.83e-05	0.000727	CbGpPWpGaD
Arsenic trioxide—AKT1—Integrated Breast Cancer Pathway—TP53—pharynx cancer	6.78e-05	0.000721	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling by EGFR in Cancer—EGFR—pharynx cancer	6.77e-05	0.00072	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling by PDGF—EGFR—pharynx cancer	6.74e-05	0.000717	CbGpPWpGaD
Arsenic trioxide—AKT1—Focal Adhesion—EGFR—pharynx cancer	6.71e-05	0.000714	CbGpPWpGaD
Arsenic trioxide—AKT1—Integrated Pancreatic Cancer Pathway—EGFR—pharynx cancer	6.69e-05	0.000711	CbGpPWpGaD
Arsenic trioxide—AKT1—Apoptosis—TP53—pharynx cancer	6.64e-05	0.000706	CbGpPWpGaD
Arsenic trioxide—AKT1—B Cell Activation—EGFR—pharynx cancer	6.58e-05	0.0007	CbGpPWpGaD
Arsenic trioxide—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—EGFR—pharynx cancer	6.57e-05	0.000699	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by FGFR in disease—EGFR—pharynx cancer	6.56e-05	0.000698	CbGpPWpGaD
Arsenic trioxide—MAPK1—DAP12 interactions—EGFR—pharynx cancer	6.56e-05	0.000698	CbGpPWpGaD
Arsenic trioxide—MAPK1—Fc epsilon receptor (FCERI) signaling—EGFR—pharynx cancer	6.56e-05	0.000698	CbGpPWpGaD
Arsenic trioxide—IKBKB—MAPK Signaling Pathway—EGFR—pharynx cancer	6.54e-05	0.000696	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by EGFR—EGFR—pharynx cancer	6.5e-05	0.000691	CbGpPWpGaD
Arsenic trioxide—MAPK3—Integrated Pancreatic Cancer Pathway—EGFR—pharynx cancer	6.49e-05	0.00069	CbGpPWpGaD
Arsenic trioxide—JUN—MAPK Signaling Pathway—TP53—pharynx cancer	6.48e-05	0.000689	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by EGFR in Cancer—EGFR—pharynx cancer	6.44e-05	0.000685	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by PDGF—EGFR—pharynx cancer	6.41e-05	0.000682	CbGpPWpGaD
Arsenic trioxide—AKT1—NGF signalling via TRKA from the plasma membrane—EGFR—pharynx cancer	6.29e-05	0.00067	CbGpPWpGaD
Arsenic trioxide—IKBKB—Fc epsilon receptor (FCERI) signaling—EGFR—pharynx cancer	6.27e-05	0.000668	CbGpPWpGaD
Arsenic trioxide—MAPK1—Integrated Breast Cancer Pathway—TP53—pharynx cancer	6.25e-05	0.000665	CbGpPWpGaD
Arsenic trioxide—AKT1—MAPK Signaling Pathway—TP53—pharynx cancer	6.22e-05	0.000662	CbGpPWpGaD
Arsenic trioxide—MAPK1—Focal Adhesion—EGFR—pharynx cancer	6.2e-05	0.000659	CbGpPWpGaD
Arsenic trioxide—MAPK1—Integrated Pancreatic Cancer Pathway—EGFR—pharynx cancer	6.17e-05	0.000656	CbGpPWpGaD
Arsenic trioxide—MAPK3—NGF signalling via TRKA from the plasma membrane—EGFR—pharynx cancer	6.1e-05	0.000649	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Metabolism—ADH1B—pharynx cancer	6.06e-05	0.000645	CbGpPWpGaD
Arsenic trioxide—MAPK3—MAPK Signaling Pathway—TP53—pharynx cancer	6.03e-05	0.000642	CbGpPWpGaD
Arsenic trioxide—JUN—Cellular Senescence—TP53—pharynx cancer	5.97e-05	0.000635	CbGpPWpGaD
Arsenic trioxide—MAPK3—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—pharynx cancer	5.9e-05	0.000628	CbGpPWpGaD
Arsenic trioxide—JUN—Integrated Pancreatic Cancer Pathway—TP53—pharynx cancer	5.84e-05	0.000622	CbGpPWpGaD
Arsenic trioxide—MAPK1—NGF signalling via TRKA from the plasma membrane—EGFR—pharynx cancer	5.81e-05	0.000618	CbGpPWpGaD
Arsenic trioxide—IKBKB—B Cell Activation—EGFR—pharynx cancer	5.81e-05	0.000618	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Metabolism—B4GALT5—pharynx cancer	5.79e-05	0.000616	CbGpPWpGaD
Arsenic trioxide—MAPK1—MAPK Signaling Pathway—TP53—pharynx cancer	5.74e-05	0.000611	CbGpPWpGaD
Arsenic trioxide—AKT1—Integrated Pancreatic Cancer Pathway—TP53—pharynx cancer	5.61e-05	0.000597	CbGpPWpGaD
Arsenic trioxide—MAPK1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—pharynx cancer	5.61e-05	0.000597	CbGpPWpGaD
Arsenic trioxide—JUN—Circadian rythm related genes—TP53—pharynx cancer	5.61e-05	0.000597	CbGpPWpGaD
Arsenic trioxide—MAPK3—Cellular Senescence—TP53—pharynx cancer	5.56e-05	0.000592	CbGpPWpGaD
Arsenic trioxide—IKBKB—MAPK Signaling Pathway—TP53—pharynx cancer	5.49e-05	0.000584	CbGpPWpGaD
Arsenic trioxide—MAPK3—Integrated Pancreatic Cancer Pathway—TP53—pharynx cancer	5.45e-05	0.000579	CbGpPWpGaD
Arsenic trioxide—CCND1—Cell Cycle—TP53—pharynx cancer	5.29e-05	0.000563	CbGpPWpGaD
Arsenic trioxide—MAPK1—Cellular Senescence—TP53—pharynx cancer	5.29e-05	0.000563	CbGpPWpGaD
Arsenic trioxide—MAPK1—Integrated Pancreatic Cancer Pathway—TP53—pharynx cancer	5.18e-05	0.000551	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—CD79A—pharynx cancer	5.14e-05	0.000547	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—CD79A—pharynx cancer	4.94e-05	0.000525	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling by NGF—EGFR—pharynx cancer	4.84e-05	0.000515	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—CD79A—pharynx cancer	4.79e-05	0.000509	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—CNDP2—pharynx cancer	4.71e-05	0.000501	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling by NGF—EGFR—pharynx cancer	4.7e-05	0.0005	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—CD79A—pharynx cancer	4.56e-05	0.000485	CbGpPWpGaD
Arsenic trioxide—AKT1—Adaptive Immune System—CDH1—pharynx cancer	4.53e-05	0.000482	CbGpPWpGaD
Arsenic trioxide—JUN—Cellular responses to stress—TP53—pharynx cancer	4.51e-05	0.00048	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by NGF—EGFR—pharynx cancer	4.47e-05	0.000475	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—CD79A—pharynx cancer	4.36e-05	0.000464	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling by NGF—EGFR—pharynx cancer	4.27e-05	0.000455	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—ADH7—pharynx cancer	4.26e-05	0.000453	CbGpPWpGaD
Arsenic trioxide—MAPK3—Axon guidance—EGFR—pharynx cancer	4.25e-05	0.000452	CbGpPWpGaD
Arsenic trioxide—MAPK3—Cellular responses to stress—TP53—pharynx cancer	4.2e-05	0.000447	CbGpPWpGaD
Arsenic trioxide—MAPK1—Axon guidance—EGFR—pharynx cancer	4.04e-05	0.00043	CbGpPWpGaD
Arsenic trioxide—IKBKB—Adaptive Immune System—CDH1—pharynx cancer	4e-05	0.000426	CbGpPWpGaD
Arsenic trioxide—MAPK3—Cell Cycle, Mitotic—CCND1—pharynx cancer	4e-05	0.000426	CbGpPWpGaD
Arsenic trioxide—MAPK1—Cellular responses to stress—TP53—pharynx cancer	4e-05	0.000425	CbGpPWpGaD
Arsenic trioxide—MAPK1—Cell Cycle, Mitotic—CCND1—pharynx cancer	3.81e-05	0.000405	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—CNDP2—pharynx cancer	3.76e-05	0.0004	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—ADH1B—pharynx cancer	3.73e-05	0.000397	CbGpPWpGaD
Arsenic trioxide—MAPK3—Cell Cycle—CCND1—pharynx cancer	3.58e-05	0.000381	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—B4GALT5—pharynx cancer	3.57e-05	0.000379	CbGpPWpGaD
Arsenic trioxide—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—pharynx cancer	3.48e-05	0.000371	CbGpPWpGaD
Arsenic trioxide—MAPK1—Cell Cycle—CCND1—pharynx cancer	3.4e-05	0.000362	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—ADH7—pharynx cancer	3.4e-05	0.000362	CbGpPWpGaD
Arsenic trioxide—AKT1—Developmental Biology—EGFR—pharynx cancer	3.13e-05	0.000333	CbGpPWpGaD
Arsenic trioxide—MAPK3—Developmental Biology—EGFR—pharynx cancer	3.03e-05	0.000323	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—ADH1B—pharynx cancer	2.98e-05	0.000317	CbGpPWpGaD
Arsenic trioxide—MAPK1—Developmental Biology—EGFR—pharynx cancer	2.89e-05	0.000307	CbGpPWpGaD
Arsenic trioxide—JUN—Innate Immune System—EGFR—pharynx cancer	2.87e-05	0.000306	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—CDH1—pharynx cancer	2.86e-05	0.000305	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—B4GALT5—pharynx cancer	2.85e-05	0.000303	CbGpPWpGaD
Arsenic trioxide—AKT1—Innate Immune System—EGFR—pharynx cancer	2.76e-05	0.000294	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—CDH1—pharynx cancer	2.75e-05	0.000293	CbGpPWpGaD
Arsenic trioxide—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—pharynx cancer	2.73e-05	0.000291	CbGpPWpGaD
Arsenic trioxide—MAPK3—Innate Immune System—EGFR—pharynx cancer	2.68e-05	0.000285	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—CDH1—pharynx cancer	2.67e-05	0.000284	CbGpPWpGaD
Arsenic trioxide—AKT1—Adaptive Immune System—EGFR—pharynx cancer	2.65e-05	0.000282	CbGpPWpGaD
Arsenic trioxide—AKT1—Hemostasis—TP53—pharynx cancer	2.58e-05	0.000274	CbGpPWpGaD
Arsenic trioxide—MAPK1—Innate Immune System—EGFR—pharynx cancer	2.55e-05	0.000271	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—CDH1—pharynx cancer	2.54e-05	0.00027	CbGpPWpGaD
Arsenic trioxide—MAPK3—Hemostasis—TP53—pharynx cancer	2.5e-05	0.000266	CbGpPWpGaD
Arsenic trioxide—IKBKB—Innate Immune System—EGFR—pharynx cancer	2.44e-05	0.000259	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—CDH1—pharynx cancer	2.43e-05	0.000258	CbGpPWpGaD
Arsenic trioxide—MAPK1—Hemostasis—TP53—pharynx cancer	2.38e-05	0.000253	CbGpPWpGaD
Arsenic trioxide—MAPK3—Cell Cycle—TP53—pharynx cancer	2.36e-05	0.000251	CbGpPWpGaD
Arsenic trioxide—IKBKB—Adaptive Immune System—EGFR—pharynx cancer	2.34e-05	0.000249	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—CNDP2—pharynx cancer	2.32e-05	0.000246	CbGpPWpGaD
Arsenic trioxide—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—pharynx cancer	2.3e-05	0.000244	CbGpPWpGaD
Arsenic trioxide—CCND1—Signaling Pathways—EGFR—pharynx cancer	2.26e-05	0.000241	CbGpPWpGaD
Arsenic trioxide—MAPK1—Cell Cycle—TP53—pharynx cancer	2.24e-05	0.000239	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—ADH7—pharynx cancer	2.09e-05	0.000223	CbGpPWpGaD
Arsenic trioxide—CCND1—Signaling Pathways—TP53—pharynx cancer	1.9e-05	0.000202	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—ADH1B—pharynx cancer	1.84e-05	0.000195	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling by GPCR—EGFR—pharynx cancer	1.76e-05	0.000187	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—B4GALT5—pharynx cancer	1.75e-05	0.000187	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling by GPCR—EGFR—pharynx cancer	1.71e-05	0.000182	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—EGFR—pharynx cancer	1.67e-05	0.000178	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by GPCR—EGFR—pharynx cancer	1.62e-05	0.000173	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—EGFR—pharynx cancer	1.61e-05	0.000171	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—EGFR—pharynx cancer	1.56e-05	0.000166	CbGpPWpGaD
Arsenic trioxide—AKT1—Disease—EGFR—pharynx cancer	1.48e-05	0.000158	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—EGFR—pharynx cancer	1.48e-05	0.000158	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—EGFR—pharynx cancer	1.44e-05	0.000153	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—EGFR—pharynx cancer	1.42e-05	0.000151	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—CCND1—pharynx cancer	1.38e-05	0.000147	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—EGFR—pharynx cancer	1.37e-05	0.000146	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—CCND1—pharynx cancer	1.33e-05	0.000141	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—CCND1—pharynx cancer	1.29e-05	0.000137	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—CCND1—pharynx cancer	1.22e-05	0.00013	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—CCND1—pharynx cancer	1.17e-05	0.000124	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—EGFR—pharynx cancer	1.08e-05	0.000115	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—EGFR—pharynx cancer	1.04e-05	0.000111	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—EGFR—pharynx cancer	1.01e-05	0.000107	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—EGFR—pharynx cancer	9.6e-06	0.000102	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—EGFR—pharynx cancer	9.18e-06	9.77e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—TP53—pharynx cancer	9.09e-06	9.67e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—TP53—pharynx cancer	8.73e-06	9.29e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—TP53—pharynx cancer	8.47e-06	9.01e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—TP53—pharynx cancer	8.06e-06	8.57e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—TP53—pharynx cancer	7.71e-06	8.2e-05	CbGpPWpGaD
